Status:
COMPLETED
Feasibility of Magnetic-end Double-J Ureteral Stent Use in Children
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Uropathy
Kidney Transplantation
Eligibility:
All Genders
Up to 17 years
Phase:
NA
Brief Summary
Double-J ureteral stent (DJUS) is one of the most common devices used in urology. Ureteral stenting has a wide spectrum of indications that can be summarized in two words: obstruction and leakage. Com...
Detailed Description
First reported in 1967, ureteral stenting evolved fast until the introduction of the double-J ureteral stent (DJUS) in 1978. It has since become one of the most common devices used in urology. Uretera...
Eligibility Criteria
Inclusion
- Child aged between 0 and 17 years and 10 months at the surgery
- Child operated at the Necker hospital for an uropathy or kidney graft need the insertion of JJ ureteral stent
- Parents or legal guardians signed the Informed consent form
- Social insurance affiliation
Exclusion
- All clinical situation need an MRI
- Contraindication with the experimental medical device (severe infections, obstruction, …)
- For the medico-economic study, a comparative group will be constituted with patients treated with classic ureteral stent in the Necker hospital in the previous years.
- This group will be matched with age (\<5 years, 5-12 years and \>13years), sex and surgery indication (kidney graft or other).
Key Trial Info
Start Date :
December 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2023
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT04384939
Start Date
December 9 2021
End Date
August 29 2023
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker
Paris, France, 75015